Natural Selection
Just What the Doctor Ordered
GlaxoSmithKline and Eli Lilly break with the rest of the drug industry on pricing and on disclosing studies and doctors' perks. Continue
You 2.0: Closing the Genetic Gap
So far, DNA websites provide mixed results. But the role of commerce is crucial to push medicine and government to take individual DNA testing seriously. Last in a four-part series. Continue
You 2.0: Recreational DNA and Genetic Voyeurism
Are there really genes for sprinting and bitter taste? A comparison of genetic traits from new online DNA testing sites with tech guru Kevin Kelly. Third in a series. Continue
You 2.0: I'm Doomed. Or Not.
According to DeCodeMe, 23andme, and Navigenics, my genes tell me that I have high, medium, and low risk for heart attack. What gives? Second in a series. Continue
You 2.0: Comparison Shopping for Your Future
Personal genetic tests are proliferating; some are even available online. Do they really tell you anything? First in a series. Continue
Stem Cells on the Brink
A closed-door meeting of global stem-cell advocates maps out the post-Bush era of research and suggests that cures may be on the horizon. Continue
The T-Rex Inside Me
A chance meeting with Paleontologist Jack “Jurassic Park” Horner connects my DNA with a 68-million-year-old tyrannosaurus rex — oh, and a chicken too. Continue
Genes 'R' Us: The New Dot-Coms?
DNA tests for everything from diseases to ancestry are proliferating as a nascent industry tries to spark a revolution. Is this déjà vu all over again? Continue
One Hell of a Trip
The PCR turns 25—a blockbuster invention that is the backbone of genetics. It was conceived late one night in 1983 by a hippie-surfer-researcher who saw nucleotides floating above a lonely country road. Continue
Gene-Sequencing Warrior
Illumina C.E.O. Jay Flatley is moving fast to outmaneuver rivals in a futuristic industry that stands to make billions of dollars off your DNA. Continue
Come on, like us—you know you want to.
Follow us and if you're an innovative entrepreneur, we'll return the favor.
Today's top stories, conversation starters, and the back nine business bites.

PREV



